The Oncology Institute, Inc.TOIIWNASDAQ
Loading
EBITDA Margin Over TimeContracting
Percentile Rank50
Year-over-Year Change
EBITDA as a percentage of revenue
Percentile
P50
Within normal range
vs 5Y Ago
-69.2x
Contraction
Streak
2 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -13.68% | +18.3% |
| 2023 | -16.74% | +37.5% |
| 2022 | -26.77% | -29.3% |
| 2021 | -20.71% | -244.0% |
| 2020 | -6.02% | -3146.7% |
| 2019 | 0.20% | -97.5% |
| 2018 | 8.02% | - |